Thiosuccinyl Peptides as Sirt5-Specific Inhibitors
- 12 January 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 134 (4), 1922-1925
- https://doi.org/10.1021/ja2090417
Abstract
Sirtuins, a class of enzymes known as nicotinamide adenine dinucleotide-dependent deacetylases, have been shown to regulate a variety of biological processes, including aging, transcription, and metabolism. Sirtuins are considered promising targets for treating several human diseases. There are seven sirtuins in humans (Sirt1–7). Small molecules that can target a particular human sirtuin are important for drug development and fundamental studies of sirtuin biology. Here we demonstrate that thiosuccinyl peptides are potent and selective Sirt5 inhibitors. The design of these inhibitors is based on our recent discovery that Sirt5 prefers to catalyze the hydrolysis of malonyl and succinyl groups, rather than an acetyl group, from lysine residues. Furthermore, among the seven human sirtuins, Sirt5 is the only one that has this unique acyl group preference. This study demonstrates that the different acyl group preferences of different sirtuins can be conveniently utilized to develop small molecules that selectively target different sirtuins.Keywords
This publication has 23 references indexed in Scilit:
- Identification of a small molecule SIRT2 inhibitor with selective tumor cytotoxicityBiochemical and Biophysical Research Communications, 2009
- Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effectOncogene, 2008
- The Sirtuin family: therapeutic targets to treat diseases of agingCurrent Opinion in Chemical Biology, 2008
- Negative regulation of the deacetylase SIRT1 by DBC1Nature, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's DiseaseScience, 2007
- Sirtuins in mammals: insights into their biological functionBiochemical Journal, 2007
- Sirtuins as potential targets for metabolic syndromeNature, 2006
- The Biochemistry of SirtuinsAnnual Review of Biochemistry, 2006
- Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 EnzymesCancer Research, 2006